Medications
Semaglutide, Tirzepatide
Monthly Cost
$199 – $399
Speed to Start
Slow: 2 to 3 Weeks
Trustpilot
Not yet rated
Compounded Medications
Est. 2026
About BreezeMeds
BreezeMeds is one of the newest entrants in the GLP-1 telehealth space, having launched in 2026. The platform offers compounded semaglutide and compounded tirzepatide at prices ranging from $199 to $399 per month. While the pricing is within the mid-range for compounded medications, the complete absence of any external validation raises immediate concerns for our editorial team. There are no Trustpilot reviews, no Better Business Bureau listing, and virtually no independent patient feedback available anywhere online.
The onboarding experience at BreezeMeds is notably slower than most competitors, with patients reporting wait times of 2 to 3 weeks before receiving their first shipment. In a market where leading providers can have medications at your door within days, this lag is a significant drawback — particularly for patients who have already made the decision to begin treatment and are eager to start. The platform does not require or offer lab testing, which means there is no baseline bloodwork to ensure patients are safe candidates for GLP-1 therapy.
From a clinical support standpoint, BreezeMeds falls short of what we consider essential. There is no dietitian access, no nutritional guidance program, and no structured ongoing support beyond the prescribing consultation. Weight loss medications work best when paired with lifestyle modifications, and the absence of any supplementary support infrastructure suggests a bare-bones, prescription-only model that may leave patients without the tools they need for long-term success.
BreezeMeds does not accept insurance, meaning all costs are entirely out-of-pocket. For a provider with zero track record, no patient reviews, and no accreditation, asking patients to commit hundreds of dollars per month requires a significant leap of faith. Our research could not verify the credentials of their medical team or the sourcing of their compounded medications, which compounds the trust deficit.
At the time of this review, BreezeMeds simply has not been around long enough to establish credibility. While every provider has to start somewhere, the combination of a brand-new launch, no external reviews, no BBB presence, slow fulfillment, and limited clinical infrastructure makes it difficult for our editorial team to recommend this provider with any confidence. We will revisit this review as the company matures and more patient data becomes available.
At a Glance
Medications Offered
Semaglutide, Tirzepatide
Compounded
Cost & Insurance
- Monthly: $199 – $399
- 6-month estimate: $1200 – $2400
- Insurance: No
- Self-pay: Yes
Clinical Features
- Lab testing: No
- Dietitian access: No
- Verified Pharmacy: Belmar Pharmacy (800-525-9473, belmarpharmasolutions.com); Strive Pharmacy (855-405-5993, strivepharmacy.com); Epiq Scripts (833-654-3553, epiqscripts.com); Casa Pharma Rx (877-937-6868, casapharmarx.com)
- BBB Rating: –
Delivery & Access
- Format: Subcutaneous
- Nationwide telehealth: Yes
- Speed: Slow: 2 to 3 Weeks
- Spanish-speaking providers: Not available
What the BreezeMeds Intake Looks Like
We walked through BreezeMeds’ full GLP-1 intake ourselves, from the goal selector through the explicit “contraindications” multi-select to the consultation-method picker and the approve-first-charge checkout. Here’s what an actual prospective patient encounters before being prescribed.
/ 10
Three sequential multi-selects with a transparent “contraindications” framing — Bipolar Disorder and Schizophrenia named explicitly (the only compounded provider in our catalog to do so), plus MTC + MEN2 personal AND family history as separate items, hypoglycemia as a discrete checkbox, and modern MASLD/MASH terminology for fatty liver. Free-text allergies and surgeries lists. Knocked down by no validated PHQ, no severity grading on eating disorders, no opiate/alcohol breakdown, and a Yes/No-only current-meds capture.
/ 10
Notably low. No early email gate — name, email, and phone aren’t collected until after every clinical question. The checkout uses an approve-first-charge mechanic (“payment will not be processed until approval is made”), and the $80 consultation fee applies only if the prescription is approved AND the patient declines treatment. Care Validate handles billing.
The 5 Stages
Clinical Safety Screens Performed
The intake doesn’t use a validated PHQ-2 or PHQ-9 depression screen and doesn’t ask about self-harm. Bipolar Disorder and Schizophrenia are listed as contraindications, but there is no separate depression checkbox or severity grading for any mental-health condition. Eating disorders are checkbox items (anorexia or bulimia) rather than a dedicated screen with severity. Substance use is collapsed into a single “Active Substance Abuse Disorder” checkbox — no opiate or alcohol breakdown. There is no actual blood pressure or heart-rate range, only checkbox items for hypertension, AFib, and tachycardia. Current medications are captured as a Yes/No only with no follow-up list visible. There’s no diet or exercise history depth, sex is collected as a binary Male / Female only, and no ID upload or phone OTP is required.
BreezeMeds combines the approve-first-charge mechanic with an unusual consultation-method choice that surfaces the fee structure transparently. The patient picks Email + Text (Fastest, free if approved & proceed), Video Call ($80 if approved & decline), or Phone Call ($80 if approved & decline). Plan-selection copy reinforces it: “Payment will not be processed until approval is made” and “After checkout, a provider will review your information to determine if treatment is right for you. Prescription is not guaranteed.” Care Validate is the third-party billing partner — patients may see CAREVALIDATE on card statements rather than BreezeMeds. The $80 charge fires only if the prescription is approved AND the patient chooses not to proceed with treatment.
Source: GLP-1.Reviews editorial walkthrough on April 30, 2026. We completed every screen of the BreezeMeds weight-loss intake using a representative GLP-1 candidate persona and stopped before submitting any payment information.
Opens breezemeds.com in a new tab.
Start your GLP-1 weight loss journey with BreezeMeds today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.
